The HemoLife brand, founded in 2013 (Germany), from 2081 sister brands and 17477 competing brands. The HemoLife brand is owned by BAYER, a company listed in Francfort. The ISIN, the company's International Securities Identification Number, is DE000BAY0017. HemoLife is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
BAYER
(HemoLife)
over 5 years*
EUR 11.25